British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

In spring 2021, my family sold a big lump of GSK shares. Four years later, we have no regrets. Indeed, with the GSK share price stumbling, we may buy soon. The post Were we right to ditch our GSK ...

GSK plc (NYSE:GSK) has failed to meet key ethical and regulatory standards in how it marketed and provided prescribing ...

(Reuters) -British pharmaceutical giant GSK has not met required ethical and regulatory standards in its marketing and prescription information for its Omjjara drug, an industry self-regulatory body ...

In a Phase 3 randomized trial of more than 600 people, an antibiotic pill called gepotidacin (normally used to treat UTIs) was found to be just as effective as the current standard course of treatment ...

A two-day meeting of the Advisory Committee on Immunization Practices (ACIP), which was originally scheduled for February but ...

China announced on Friday that it would raise its levies on imports of U.S. goods to 125%, hitting back at U.S. President Donald Trump's decision to single out the world's second-largest economy for ...

Spread This NewsBBC Scientists believe they have found a new effective antibiotic for gonorrhoea, which could be one of the most promising in decades. Gepotidacin can treat and clear the sexually ...

A new pill has shown promise against antibiotic-resistant gonorrhoea -- a common sexually transmitted infection (STI) --, ...

Discover insights from Johnson & Johnson's Q1 2025 earnings call, highlighting 4.2% sales growth, MedTech innovation, and strategies to offset ...

Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...

Because RNAs are so central to our biology, they are also drivers of a wide array of diseases. Defects in how RNA is produced ...